Shares Investor Evening - Webinar

Webinar
Tuesday, May 19, 2020 - 06:00 PM
Until: Tuesday, May 19, 2020 - 07:19 PM
(Adjusted for timezone: Europe/London)
Categories
Come online and join Shares and AJ Bell Media at their next webinar on Tuesday 19 May 2020 which can be accessed from wherever you are!
Shares Spotlight webinars feature presentations from directors of listed companies explaining their investment propositions followed by an opportunity for you to ask questions. This is your chance to hear first-hand from the people making the decisions on what these companies do and how they are going to generate shareholder value.
Accessing the webinar is very simple; simply register your details and follow the link that you will receive in your confirmation email at the scheduled time of the webinar.
The webinar will not require your participation in the form of audio or video, however you will have the opportunity to ask questions to the presenters via an online chat window during the webinar.
The webinar will follow a similar format to our regular Shares Investor Evenings, and is open to any existing shareholders or potential investors.
The webinar will feature the following companies:
e-Therapeutics (ETX) is a drug discovery company. The company's discovery platform is based on the network of pharmacology and chemical biology. e-Therapeutics operates in a segment of drug discovery and development.
Kore Potash (KP2) is an advanced stage mineral exploration and development company whose primary asset is 97%-owned interest in the Sintoukola project, a potash project located in the Republic of Congo.
+ more to be announced...


Click on the REGISTER tab now to secure your place!
Who Should Attend
The evening exposes investors to companies across various sectors. Perfect for existing investors as well as those looking for new investment opportunities.
Evening timings
18.00 Introduction
Roland Spencer, Head of Sales - Shares
18.05 Kore Potash
Brad Sampson, CEO - Kore Potash (KP2)
18.30 e-Therapeutics
Ali Mortazavi, Executive Chairman - e-Therapeutics (ETX)
18.55 Presentation 3 - to be confirmed
19.20 End of event
Top